title: Stroke MRI may result in a therapeutic dilemma.
authors.forename: L
authors.initials: L
authors.lastname: Mechtouff
authors.forename: M
authors.initials: M
authors.lastname: Hermier
authors.forename: B
authors.initials: B
authors.lastname: Nader
authors.forename: S
authors.initials: S
authors.lastname: Cartalat
authors.forename: L
authors.initials: L
authors.lastname: Derex
authors.forename: S
authors.initials: S
authors.lastname: Cakmak
authors.forename: J
authors.initials: J
authors.lastname: Honnorat
authors.forename: N
authors.initials: N
authors.lastname: Nighoghossian
mesh_terms: D000368:Aged; D001281:Atrial Fibrillation / Q000150:complications; D001921:Brain / Q000473:pathology*; D002543:Cerebral Hemorrhage / Q000150:complications / Q000175:diagnosis* / Q000628:therapy*; D002544:Cerebral Infarction / Q000150:complications / Q000175:diagnosis* / Q000628:therapy*; D003920:Diabetes Mellitus; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000150:complications; D020925:Hypoxia-Ischemia, Brain / Q000150:complications / Q000175:diagnosis / Q000628:therapy; D008279:Magnetic Resonance Imaging; D008297:Male; D014057:Tomography, X-Ray Computed
chemical_list: D006495:Heparin, Low-Molecular-Weight